Impact of the rs1050757 C > T variant in the 3'UTR of the G6PD gene on mRNA structure and miRNA binding in G6PD deficiency: a nanopore MinION sequencing study

Authors

  • Lawrence Billy Vasco Djama Medical Sciences Program, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • Vorthon Sawaswong Faculty of Science, Mahidol University, Bangkok, Thailand
  • Prangwalai Chanchaem Center of Excellence in Systems Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • Punchalee Mungkalasut Interdisciplinary Program of Biomedical Sciences, Graduate School, Chulalongkorn University, Bangkok, Thailand
  • Thanaporn Pimpakan Medical Sciences Program, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • Poonlarp Cheepsunthorn Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • Sunchai Payungporn Center of Excellence in Systems Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
  • Chalisa Louicharoen Cheepsunthorn Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Keywords:

3' UTR, G6PD deficiency, glucose 6-phosphate dehydrogenase, miRNA binding, mRNA secondary structure, nanopore MinION sequencing, noncoding mutations, regulatory regions, rs1050757

Abstract

Background: Glucose 6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder caused by impaired enzyme function or instability due to mutations in the G6PD gene, resulting in reduced enzyme activity. This study aimed to investigate mutations within the regulatory regions of the G6PD gene using Nanopore MinION sequencing to investigate the potential effects of noncoding variants on G6PD activity.

Methods: Blood samples from 19 males (13 adults and 6 neonates) with G6PD deficiency or intermediate enzyme activity but with unidentified coding sequence mutations were analyzed. Genomic DNA was amplified using degenerate oligonucleotide-primed PCR and sequenced on the Oxford Nanopore MinION platform. Bioinformatic analyses were performed to evaluate the effects of single-nucleotide polymorphisms on G6PD mRNA structure and miRNA binding potential.

Results: The rs1050757 C > T variant in the 3' untranslated region (3' UTR) of theG6PD gene was detected in 12 individuals, including 9 individuals with intermediate G6PD activity (7 adults and 2 neonates) and 3 neonates with G6PD deficiency. Among adults, G6PD activity was comparable between carriers of the T (11.5 ± 1.3 U/g Hb, n = 7) and C (11.8 ± 0.8 U/g Hb, n = 6) alleles. However, G6PD activity was more variable in neonates, with mean values of 1.8 ± 4.0 U/g Hb for the T allele (n = 5) and 6.0 U/g Hb for the C allele (n = 1). No cases of hemolytic anemia were observed in individuals carrying the rs1050757 variant, suggesting a limited direct effect on enzyme function. Computational analyses revealed that the variant induced minor alterations in the secondary structure of the G6PD mRNA, resulting in a shift in the Gibbs free energy (ΔG) from −425.0 to −412.1 kcal/mol and the minimum free energy from−441.1 to −440.4 kcal/mol. These changes may subtly influence mRNA loop formation and miRNA binding at the hsa-miR-92b-3p site.

Conclusion: The rs1050757 variant appears to exert a limited effect on G6PD activity and clinical phenotype. Nevertheless, its potential role in modulating gene regulation through alterations in mRNA structure or miRNA interaction warrants further investigation. Improved understanding of noncoding region mutations may improve diagnostic accuracy and facilitate genotype–phenotype correlations, particularly in malariaendemic regions where G6PD deficiency screening is crucial.

Downloads

Download data is not yet available.

References

Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008;371:64 -74.

https://doi.org/10.1016/S0140-6736(08)60073-2

Domingo GJ, Advani N, Satyagraha AW, Sibley CH, Rowley E, Kalnoky M, et al. Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities. Int Health 2019;11:7-14.

https://doi.org/10.1093/inthealth/ihy060

Pimpakan T, Mungkalasut P, Tansakul P, Chanda M, Jugnam-Ang W, Charucharana S, et al. Effect of neonatal reticulocytosis on glucose 6-phosphate dehydrogenase (G6PD) activity and G6PD deficiency detection: a cross-sectional study. BMC Pediatr. 2022;22:678.

https://doi.org/10.1186/s12887-022-03740-1

Cheepsunthorn CL, Nilsri N. Prevalence of glucose 6- phosphate dehydrogenase deficiency and molecular genetics of G6PD in Thai population of Phayao province. Journal of Hematology and Transfusion Medicine 2015;25:131-7.

Faiyaz-Ul-Haque M, Zaidi SH, Hasanato RM, AlAbdullatif A, Cluntun A, Teresita G, et al. Genetics of glucose-6-phosphate dehydrogenase deficiency in Saudi patients. Clin Genet 2010;78:98-100.

https://doi.org/10.1111/j.1399-0004.2010.01377.x

Ninokata A, Kimura R, Samakkarn U, SettheethamIshida W, Ishida T. Coexistence of five G6PD variants indicates ethnic complexity of Phuket islanders, Southern Thailand. J Hum Genet 2006;51:424-8.

https://doi.org/10.1007/s10038-006-0380-y

Ainoon O, Joyce J, Boo NY, Cheong SK, Zainal ZA, Hamidah NH. Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Chinese. Hum Mutat 1999;14:352.

https://doi.org/10.1002/(SICI)1098-1004(199910)14:4<352::AID-HUMU14>3.0.CO;2-G

Amini F, Ismail E, Zilfalil BA. Prevalence and molecular study of G6PD deficiency in Malaysian Orang Asli. Intern Med J 2011;41:351-3.

https://doi.org/10.1111/j.1445-5994.2011.02456.x

Nuchprayoon I, Sanpavat S, Nuchprayoon S. Glucose 6 phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G> A) is the most common deficiency variant in the Thai population. Human mutation 2002;19:185.

https://doi.org/10.1002/humu.9010

Riethoven JJ. Regulatory regions in DNA: promoters, enhancers, silencers, and insulators. Methods Mol Biol 2010;674:33-42.

https://doi.org/10.1007/978-1-60761-854-6_3

Mungkalasut P, Nimsamer P, Cheepsunthorn P, Payungporn S, Cheepsunthorn CL. Single-drop blood detection of common G6PD mutations in Thailand based on allele-specific recombinase polymerase amplification with CRISPR-Cas12a. ACS Omega 2023;8:44733-44.

https://doi.org/10.1021/acsomega.3c05596

Telenius H, Carter NP, Bebb CE, Nordenskjold M, Ponder BA, Tunnacliffe A. Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer. Genomics 1992;13:718-25.

https://doi.org/10.1016/0888-7543(92)90147-K

Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-inone FASTQ preprocessor. Bioinformatics 2018;34: i884-i90.

https://doi.org/10.1093/bioinformatics/bty560

Golosova O, Henderson R, Vaskin Y, Gabrielian A, Grekhov G, Nagarajan V, et al. Unipro UGENE NGS pipelines and components for variant calling, RNAseq and ChIP-seq data analyses. PeerJ 2014;2:e644.

https://doi.org/10.7717/peerj.644

Bellaousov S, Reuter JS, Seetin MG, Mathews DH. RNAstructure: web servers for RNA secondary structure prediction and analysis. Nucleic Acids Res 2013;41:W471-4.

https://doi.org/10.1093/nar/gkt290

Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res 2008;36:W70-4.

https://doi.org/10.1093/nar/gkn188

Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005;120:15-20.

https://doi.org/10.1016/j.cell.2004.12.035

John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol 2004;2:e363.

https://doi.org/10.1371/journal.pbio.0020363

Tastsoglou S, Alexiou A, Karagkouni D, Skoufos G, Zacharopoulou E, Hatzigeorgiou AG. DIANA-microT 2023: including predicted targets of virally encoded miRNAs. Nucleic Acids Res 2023;51:W148-53.

https://doi.org/10.1093/nar/gkad283

Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: an online resource for prediction of microRNA binding sites. PLoS One 2018;13:e0206239.

https://doi.org/10.1371/journal.pone.0206239

Garcia AA, Koperniku A, Ferreira JCB, Mochly-Rosen D. Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives. Trends Pharmacol Sci 2021;42:829-44.

https://doi.org/10.1016/j.tips.2021.07.002

Philippe M, Larondelle Y, Lemaigre F, Mariame B, Delhez H, Mason P, et al. Promoter function of the human glucose-6-phosphate dehydrogenase gene depends on two GC boxes that are cell specifically controlled. Eur J Biochem 1994;226:377-84.

https://doi.org/10.1111/j.1432-1033.1994.tb20062.x

Franze A, Ferrante MI, Fusco F, Santoro A, Sanzari E, Martini G, et al. Molecular anatomy of the human glucose 6-phosphate dehydrogenase core promoter. FEBS Lett 1998;437:313-8.

https://doi.org/10.1016/S0014-5793(98)01259-9

Shao X, Zhang C, Sun MA, Lu X, Xie H. Deciphering the heterogeneity in DNA methylation patterns during stem cell differentiation and reprogramming. BMC Genomics 2014;15:978.

https://doi.org/10.1186/1471-2164-15-978

Bogdanovic O, Veenstra GJ. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009;118: 549-65.

https://doi.org/10.1007/s00412-009-0221-9

Amini F, Ismail E. 3'-UTR variations and G6PD deficiency. J Hum Genet 2013;58:189-94.

https://doi.org/10.1038/jhg.2012.155

Chaowanathikhom M, Nuchnoi P, Palasuwan D. Significance of 3'UTR and pathogenic haplotype in glucose-6-phosphate deficiency. Lab Med 2017; 48:73-88.

https://doi.org/10.1093/labmed/lmw065

Drew HR, Lewy D, Conaty J, Rand KN, Hendry P, Lockett T. RNA hairpin loops repress protein synthesis more strongly than hammerhead ribozymes. Eur J Biochem 1999;266:260-73.

https://doi.org/10.1046/j.1432-1327.1999.00864.x

Zhang M, Lam TT, Tonelli M, Marzluff WF, Thapar R. Interaction of the histone mRNA hairpin with stemloop binding protein (SLBP) and regulation of the SLBP-RNA complex by phosphorylation and proline isomerization. Biochemistry 2012;51:3215-31.

https://doi.org/10.1021/bi2018255

Groebe DR, Uhlenbeck OC. Thermal stability of RNA hairpins containing a four-membered loop and a bulge nucleotide. Biochemistry 1988;28:742-7.

https://doi.org/10.1021/bi00428a049

Zhuang Y, Lu X, Lin P, Wang S, Sheng X, Chen C, et al. Impact of the RNA allosteric effect triggered by single nucleotide polymorphisms on the splicing process. Hum Mol Genet 2023;32:2229-40.

https://doi.org/10.1093/hmg/ddad057

Uddin SN, Majumder A, Islam KK, Hossain SA, Sarker PK. Minimum free energy based evaluation of mRNAs secondary structures constructed by 18 clinically significant exonic single nucleotide polymorphisms (SNPs) and haplotypes of 5 missense SNPs of RB1 gene. AJBB 2015;11:191-9.

https://doi.org/10.3844/ajbbsp.2015.191.199

Luzzatto L, Bancone G, Dugue PA, Jiang W, Minucci A, Nannelli C, et al. New WHO classification of genetic variants causing G6PD deficiency. Bull World Health Organ 2024;102:615-7.

https://doi.org/10.2471/BLT.23.291224

Geck RC, Powell NR, Dunham MJ. Functional interpretation, cataloging, and analysis of 1,341 glucose-6-phosphate dehydrogenase variants. Am J Hum Genet 2023;110:228-39.

https://doi.org/10.1016/j.ajhg.2023.01.003

Published

2025-11-28

How to Cite

1.
Billy Vasco Djama L, Sawaswong V, Chanchaem P, Mungkalasut P, Pimpakan T, Cheepsunthorn P, Payungporn S, Louicharoen Cheepsunthorn C. Impact of the rs1050757 C > T variant in the 3’UTR of the G6PD gene on mRNA structure and miRNA binding in G6PD deficiency: a nanopore MinION sequencing study. Chula Med J [internet]. 2025 Nov. 28 [cited 2025 Dec. 8];69(6). available from: https://he05.tci-thaijo.org/index.php/CMJ/article/view/7019